Search consultations


Changes to funding of Ciproflaxin for chronic suppurative otitis media (CSOM)

NZNO seeks members’ feedback on PHARMAC’s proposal to widen access to ciproflaxin eyedrops for the treatment of chronic suppurative otitis media (CSOM).

Please note this proposal was amended on 14 August following concerns around its use in otitis externa.

Access the amended proposal here:

Feedback due: Please send feedback to by 25 August 2017.

Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Enter the code shown above in the box below.